Sort
130,381 grants matching “hiv”
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,977,792Glenn Wasserman · Hawaii State Department Of Health · U62 · FY2012 · PS
Center for Translational Viral Oncology (CTVO)
$1,977,766Krzysztof Reiss · Lsu Health Sciences Center · P20 · FY2021 · GM
MBRS-SCORE PROGRAM AT UPR, MEDICAL SCIENCES CAMPUS
$1,977,529University Of Puerto Rico Med Sciences · S06 · FY2001 · GM
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$1,977,473Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2013 · AI
Center for AIDS Research
$1,977,464Fred Valentine · New York University School Of Medicine · P30 · FY2009 · AI
Case Clinical Trials Unit
$1,977,369Michael Marcel Lederman · Case Western Reserve University · UM1 · FY2017 · AI
Adjuvant development within the context of a vaccine to protect against B. pertussis
$1,977,192Lisa Morici · Tulane University Of Louisiana · N01 · FY2021 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$1,977,185Jeffrey Lennox · Emory University · UM1 · FY2015 · AI
Pacific Center for Emerging Infectious Diseases Research
$1,976,997Richard Yanagihara · University Of Hawaii At Manoa · P20 · FY2013 · GM
Flow cytometric analysis of benign and malignant tumors
$1,976,620Hao-Wei Wang · Division Of Clinical Sciences - Nci · ZIC · FY2022 · CA
GENERAL CLINICAL RESEARCH CENTER
$1,976,557University Of Colorado Denver · M01 · FY2000 · RR
HIV VACCINE TRIAL CLINICAL UNIT
$1,976,524Harvard University (Medical School) · U01 · FY2001 · AI
Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Env
$1,975,833Shan Lu · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · AI
Patient reported outcomes in routine clinical care of patients infected with HIV
$1,975,638Heidi M. Crane · University Of Washington · U01 · FY2012 · AR
SUPPORT UGANDA MINISTRY OF HEALTH'S CAPACITY TO ADDRESS HIV RESPONSE THROUGH STRE
$1,975,454Jane Aceng · Aids Control Programme · U2G · FY2013 · GH
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
$1,974,976Vactor Hadijah · Icahn School Of Medicine At Mount Sinai · N01 · FY2023 · MH
Shaping Antiviral Immunity by the Inflammatory, Regulatory and Tissue Environment
$1,974,689E. John Wherry · University Of Pennsylvania · U19 · FY2010 · AI
HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027
$1,974,550Linda-Gail Bekker · University Of Cape Town · UM1 · FY2023 · AI
NIDA Clinical Trials Network: Greater New York Node
$1,974,434John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
HIV Vaccine Design and Development Team
$1,974,283Progenics Pharmaceuticals, Inc. · R01 · FY2000 · AI
Third Coast Center for AIDS Research
$1,974,259Richard T D'aquila · Northwestern University At Chicago · P30 · FY2016 · AI
Vaccination against mucosal HIV clade C transmission
$1,974,218Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2009 · AI
Antiretroviral Treatment Interruption as a Long-term Therapeutic Strategy
$1,973,961Steven Reynolds · Niaid Extramural Activities · Z01 · FY2007 · AI
Mentoring Oral Health Research in Louisiana
$1,973,374Paul L Fidel · Lsu Health Sciences Center · P20 · FY2008 · RR
Zimbabwe: Community Intervention to Reduce HIV/STD Risk
$1,973,332Battelle Centers/Pub Hlth Res &Evaluatn · U10 · FY2004 · MH